Technical Specification
Track updates
ATS 4888.1-2013
[Current]Electronic transfer of prescriptions, Part 1: Platform independent (logical) information model to support electronic transfer of prescriptions
A platform independent (logical) information model for an electronic prescription, specifying the information structure of e-prescriptions in order to support the electronic transfer of prescriptions (ETP). The first in a series of six Technical Specifications that collectively define a method for ETP in Australia.
Published: 20/05/2013
Pages: 225
Table of contents
Cited references
Content history
Table of contents
Header
About this publication
Preface
1 Scope and general
1.1 Scope
1.2 Intended audience
1.3 Normative references
1.4 Terms, definitions and acronyms
1.4.1 Terms and definitions
1.4.2 Definitions
1.4.3 Acronyms
1.5 Keyword interpretations
1.5.1 Interpretation of normative language
1.5.2 Cardinality obligations legend
1.6 Regulatory compliance
1.7 Icon legend
1.7.1 Icons for metadata types
1.7.2 Icons for data types
1.8 Known issues
2 Prescription structured document
2.1 E-prescription
2.1.1 Identification
2.1.2 Definition
2.1.3 Usage
2.2 Data hierarchy
3 E-prescription context
3.1 Subject of care
3.1.1 Identification
3.1.2 Definition
3.1.3 Usage
3.1.4 Relationships
3.2 Subject of care entitlement type values
3.2.1 Identification
3.2.2 Definition
3.2.3 Value domain
3.2.4 Relationships
3.3 Prescriber
3.3.1 Identification
3.3.2 Definition
3.3.3 Usage
3.3.4 Relationships
3.4 Prescriber organization
3.4.1 Identification
3.4.2 Definition
3.4.3 Usage
3.4.4 Relationships
3.5 Prescription identifier
3.5.1 Identification
3.5.2 Definition
3.5.3 Usage
3.5.4 Relationships
4 Prescription item
4.1 Prescription item
4.1.1 Identification
4.1.2 Definition
4.1.3 Usage
4.1.4 Relationships
4.2 Datetime prescription written
4.2.1 Identification
4.2.2 Definition
4.2.3 Usage
4.2.4 Relationships
4.3 Datetime prescription expires
4.3.1 Identification
4.3.2 Definition
4.3.3 Usage
4.3.4 Relationships
4.4 Prescription item identifier
4.4.1 Identification
4.4.2 Definition
4.4.3 Usage
4.4.4 Relationships
4.5 Therapeutic good identification
4.5.1 Identification
4.5.2 Definition
4.5.3 Usage
4.5.4 Relationships
4.6 Medicines terminology
4.6.1 Identification
4.6.2 Definition
4.6.3 Value domain
4.6.4 Relationships
4.7 Formula
4.7.1 Identification
4.7.2 Definition
4.7.3 Usage
4.7.4 Relationships
4.8 Directions
4.8.1 Identification
4.8.2 Definition
4.8.3 Usage
4.8.4 Relationships
4.9 Structured dose
4.9.1 Identification
4.9.2 Definition
4.9.3 Usage
4.9.4 Relationships
4.10 Quantity
4.10.1 Identification
4.10.2 Definition
4.10.3 Relationships
4.11 Dose unit
4.11.1 Identification
4.11.2 Definition
4.11.3 Usage
4.11.4 Relationships
4.12 Dose unit reference set
4.12.1 Identification
4.12.2 Definition
4.12.3 Value domain
4.12.4 Relationships
4.13 Quantity description
4.13.1 Identification
4.13.2 Definition
4.13.3 Relationships
4.14 Timing
4.14.1 Identification
4.14.2 Definition
4.14.3 Usage
4.14.4 Relationships
4.15 Timing description
4.15.1 Identification
4.15.2 Definition
4.15.3 Usage
4.15.4 Relationships
4.16 Structured timing
4.16.1 Identification
4.16.2 Definition
4.16.3 Relationships
4.17 Intervention frequency range
4.17.1 Identification
4.17.2 Definition
4.17.3 Relationships
4.18 Intervention interval range
4.18.1 Identification
4.18.2 Definition
4.18.3 Relationships
4.19 Intervention time
4.19.1 Identification
4.19.2 Definition
4.19.3 Relationships
4.20 Intervention day of week
4.20.1 Identification
4.20.2 Definition
4.20.3 Usage
4.20.4 Relationships
4.21 Intervention day of week values
4.21.1 Identification
4.21.2 Definition
4.21.3 Value domain
4.21.4 Relationships
4.22 Intervention day of month
4.22.1 Identification
4.22.2 Definition
4.22.3 Relationships
4.23 Intervention date
4.23.1 Identification
4.23.2 Definition
4.23.3 Relationships
4.24 PRN
4.24.1 Identification
4.24.2 Definition
4.24.3 Relationships
4.25 Start criterion
4.25.1 Identification
4.25.2 Definition
4.25.3 Relationships
4.26 Start date
4.26.1 Identification
4.26.2 Definition
4.26.3 Relationships
4.27 Stop criterion
4.27.1 Identification
4.27.2 Definition
4.27.3 Relationships
4.28 Stop date
4.28.1 Identification
4.28.2 Definition
4.28.3 Relationships
4.29 Duration of treatment
4.29.1 Identification
4.29.2 Definition
4.29.3 Relationships
4.30 Number of administrations
4.30.1 Identification
4.30.2 Definition
4.30.3 Relationships
4.31 Long-term
4.31.1 Identification
4.31.2 Definition
4.31.3 Relationships
4.32 Administration details
4.32.1 Identification
4.32.2 Definition
4.32.3 Usage
4.32.4 Relationships
4.33 Route
4.33.1 Identification
4.33.2 Definition
4.33.3 Usage
4.33.4 Relationships
4.34 Route of administration reference set
4.34.1 Identification
4.34.2 Definition
4.34.3 Value domain
4.34.4 Relationships
4.35 Anatomical site
4.35.1 Identification
4.35.2 Definition
4.35.3 Usage
4.35.4 Relationships
4.36 Body structure foundation reference set
4.36.1 Identification
4.36.2 Definition
4.36.3 Value domain
4.36.4 Relationships
4.37 Medication delivery method
4.37.1 Identification
4.37.2 Definition
4.37.3 Usage
4.37.4 Relationships
4.38 Dose duration
4.38.1 Identification
4.38.2 Definition
4.38.3 Usage
4.38.4 Relationships
4.39 Quantity to dispense
4.39.1 Identification
4.39.2 Definition
4.39.3 Relationships
4.40 Quantity
4.40.1 Identification
4.40.2 Definition
4.40.3 Relationships
4.41 Dispensing unit
4.41.1 Identification
4.41.2 Definition
4.41.3 Usage
4.41.4 Relationships
4.42 Dose unit reference set
4.42.1 Identification
4.42.2 Definition
4.42.3 Value domain
4.42.4 Relationships
4.43 Quantity description
4.43.1 Identification
4.43.2 Definition
4.43.3 Relationships
4.44 Brand substitute not allowed
4.44.1 Identification
4.44.2 Definition
4.44.3 Usage
4.44.4 Relationships
4.45 Maximum number of repeats
4.45.1 Identification
4.45.2 Definition
4.45.3 Usage
4.45.4 Relationships
4.46 Minimum interval between repeats
4.46.1 Identification
4.46.2 Definition
4.46.3 Usage
4.46.4 Relationships
4.47 PBS prescription type
4.47.1 Identification
4.47.2 Definition
4.47.3 Usage
4.47.4 Relationships
4.48 PBS prescription type values
4.48.1 Identification
4.48.2 Definition
4.48.3 Value domain
4.48.4 Relationships
4.49 Medical benefit category type
4.49.1 Identification
4.49.2 Definition
4.49.3 Relationships
4.50 Medical benefit category type values
4.50.1 Identification
4.50.2 Definition
4.50.3 Value domain
4.50.4 Relationships
4.51 PBS close the gap benefit
4.51.1 Identification
4.51.2 Definition
4.51.3 Usage
4.51.4 Relationships
4.52 PBS/RPBS item code
4.52.1 Identification
4.52.2 Definition
4.52.3 Usage
4.52.4 Relationships
4.53 PBS/RPBS item code values
4.53.1 Identification
4.53.2 Definition
4.53.3 Value domain
4.53.4 Relationships
4.54 PBS/RPBS manufacturer code
4.54.1 Identification
4.54.2 Definition
4.54.3 Usage
4.54.4 Relationships
4.55 PBS/RPBS Manufacturer Code Values
4.55.1 Identification
4.55.2 Definition
4.55.3 Value domain
4.55.4 Relationships
4.56 PBS extemporaneous preparation description
4.56.1 Identification
4.56.2 Definition
4.56.3 Usage
4.56.4 Relationships
4.57 PBS extemporaneous ingredient
4.57.1 Identification
4.57.2 Definition
4.57.3 Usage
4.57.4 Relationships
4.58 PBS extemporaneous ingredient name
4.58.1 Identification
4.58.2 Definition
4.58.3 Usage
4.58.4 Relationships
4.59 PBS extemporaneous ingredient quantity
4.59.1 Identification
4.59.2 Definition
4.59.3 Relationships
4.60 Grounds for concurrent supply
4.60.1 Identification
4.60.2 Definition
4.60.3 Usage
4.60.4 Relationships
4.61 Grounds for concurrent supply values
4.61.1 Identification
4.61.2 Definition
4.61.3 Value domain
4.61.4 Relationships
4.62 PBS/RPBS authority prescription number
4.62.1 Identification
4.62.2 Definition
4.62.3 Usage
4.62.4 Relationships
4.63 PBS/RPBS authority approval number
4.63.1 Identification
4.63.2 Definition
4.63.3 Usage
4.63.4 Relationships
4.64 Streamlined authority approval number
4.64.1 Identification
4.64.2 Definition
4.64.3 Usage
4.64.4 Relationships
4.65 State authority number
4.65.1 Identification
4.65.2 Definition
4.65.3 Usage
4.65.4 Relationships
4.66 Reason for therapeutic good
4.66.1 Identification
4.66.2 Definition
4.66.3 Usage
4.66.4 Relationships
4.67 Additional comments
4.67.1 Identification
4.67.2 Definition
4.67.3 Usage
4.67.4 Relationships
4.68 Dispense item identifier
4.68.1 Identification
4.68.2 Definition
4.68.3 Usage
4.68.4 Relationships
4.69 Medication instruction identifier
4.69.1 Identification
4.69.2 Definition
4.69.3 Usage
4.69.4 Relationships
5 Observations section
5.1 Observations
5.1.1 Identification
5.1.2 Definition
5.1.3 Relationships
5.2 Body weight
5.2.1 Identification
5.2.2 Definition
5.2.3 Usage
5.2.4 Relationships
5.3 Body weight value
5.3.1 Identification
5.3.2 Definition
5.3.3 Usage
5.3.4 Relationships
5.4 Datetime of observation
5.4.1 Identification
5.4.2 Definition
5.4.3 Usage
5.4.4 Relationships
5.5 Body height
5.5.1 Identification
5.5.2 Definition
5.5.3 Relationships
5.6 Body height value
5.6.1 Identification
5.6.2 Definition
5.6.3 Usage
5.6.4 Relationships
5.7 Datetime of observation
5.7.1 Identification
5.7.2 Definition
5.7.3 Usage
5.7.4 Relationships
6 Prescription note detail
6.1 Prescription note detail
6.1.1 Identification
6.1.2 Definition
6.1.3 Relationships
6.2 Note
6.2.1 Identification
6.2.2 Definition
6.2.3 Usage
6.2.4 Relationships
7 Dispense record structured document
7.1 Dispense record
7.1.1 Identification
7.1.2 Definition
7.1.3 Data hierarchy
8 Dispense record context
8.1 Subject of care
8.1.1 Identification
8.1.2 Definition
8.1.3 Usage
8.1.4 Relationships
8.2 Subject of care entitlement type values
8.2.1 Identification
8.2.2 Definition
8.2.3 Value domain
8.2.4 Relationships
8.3 Dispenser
8.3.1 Identification
8.3.2 Definition
8.3.3 Usage
8.3.4 Relationships
8.4 Dispensing organization
8.4.1 Identification
8.4.2 Definition
8.4.3 Usage
8.4.4 Relationships
8.5 Dispense record identifier
8.5.1 Identification
8.5.2 Definition
8.5.3 Usage
8.5.4 Relationships
9 Dispense item
9.1 Dispense item
9.1.1 Identification
9.1.2 Definition
9.1.3 Relationships
9.2 Dispense item identifier
9.2.1 Identification
9.2.2 Definition
9.2.3 Usage
9.2.4 Relationships
9.3 Datetime of dispense event
9.3.1 Identification
9.3.2 Definition
9.3.3 Usage
9.3.4 Relationships
9.4 Prescription item identifier
9.4.1 Identification
9.4.2 Definition
9.4.3 Usage
9.4.4 Relationships
9.5 Therapeutic good identification
9.5.1 Identification
9.5.2 Definition
9.5.3 Usage
9.5.4 Relationships
9.6 Medicines terminology
9.6.1 Identification
9.6.2 Definition
9.6.3 Value domain
9.6.4 Relationships
9.7 Formula
9.7.1 Identification
9.7.2 Definition
9.7.3 Usage
9.7.4 Relationships
9.8 Label instruction
9.8.1 Identification
9.8.2 Definition
9.8.3 Relationships
9.9 Quantity dispensed
9.9.1 Identification
9.9.2 Definition
9.9.3 Relationships
9.10 Quantity
9.10.1 Identification
9.10.2 Definition
9.10.3 Relationships
9.11 Dispensing unit
9.11.1 Identification
9.11.2 Definition
9.11.3 Usage
9.11.4 Relationships
9.12 Dose unit reference set
9.12.1 Identification
9.12.2 Definition
9.12.3 Value domain
9.12.4 Relationships
9.13 Quantity description
9.13.1 Identification
9.13.2 Definition
9.13.3 Relationships
9.14 Brand substitution occurred
9.14.1 Identification
9.14.2 Definition
9.14.3 Usage
9.14.4 Relationships
9.15 Maximum number of repeats
9.15.1 Identification
9.15.2 Definition
9.15.3 Usage
9.15.4 Relationships
9.16 Number of this dispense
9.16.1 Identification
9.16.2 Definition
9.16.3 Usage
9.16.4 Relationships
9.17 PBS close the gap benefit
9.17.1 Identification
9.17.2 Definition
9.17.3 Usage
9.17.4 Relationships
9.18 PBS/RPBS item code
9.18.1 Identification
9.18.2 Definition
9.18.3 Usage
9.18.4 Relationships
9.19 PBS/RPBS Item Code Values
9.19.1 Identification
9.19.2 Definition
9.19.3 Value domain
9.19.4 Relationships
9.20 PBS/RPBS Manufacturer code
9.20.1 Identification
9.20.2 Definition
9.20.3 Usage
9.20.4 Relationships
9.21 PBS/RPBS Manufacturer Code Values
9.21.1 Identification
9.21.2 Definition
9.21.3 Value domain
9.21.4 Relationships
9.22 PBS Extemporaneous preparation description
9.22.1 Identification
9.22.2 Definition
9.22.3 Usage
9.22.4 Relationships
9.23 PBS Extemporaneous ingredient
9.23.1 Identification
9.23.2 Definition
9.23.3 Usage
9.23.4 Relationships
9.24 PBS Extemporaneous ingredient name
9.24.1 Identification
9.24.2 Definition
9.24.3 Usage
9.24.4 Relationships
9.25 PBS Extemporaneous Ingredient Quantity
9.25.1 Identification
9.25.2 Definition
9.25.3 Relationships
9.26 Claim category type
9.26.1 Identification
9.26.2 Definition
9.26.3 Usage
9.26.4 Relationships
9.27 Claim category type values
9.27.1 Identification
9.27.2 Definition
9.27.3 Value domain
9.27.4 Relationships
9.28 Under co-payment
9.28.1 Identification
9.28.2 Definition
9.28.3 Usage
9.28.4 Relationships
9.29 Early supply with pharmaceutical benefit
9.29.1 Identification
9.29.2 Definition
9.29.3 Usage
9.29.4 Relationships
9.30 Additional comments
9.30.1 Identification
9.30.2 Definition
9.30.3 Usage
9.30.4 Relationships
9.31 Patient category
9.31.1 Identification
9.31.2 Definition
9.31.3 Usage
9.31.4 Relationships
9.32 Patient category values
9.32.1 Identification
9.32.2 Definition
9.32.3 Value domain
9.32.4 Relationships
9.33 RACF ID
9.33.1 Identification
9.33.2 Definition
9.33.3 Usage
9.33.4 Relationships
10 Prescription request structured document
10.1 Prescription request
10.1.1 Identification
10.1.2 Definition
10.1.3 Data hierarchy
11 Prescription request context
11.1 Subject of care
11.1.1 Identification
11.1.2 Definition
11.1.3 Usage
11.1.4 Relationships
11.2 Subject of care entitlement type values
11.2.1 Identification
11.2.2 Definition
11.2.3 Value domain
11.2.4 Relationships
11.3 Dispenser
11.3.1 Identification
11.3.2 Definition
11.3.3 Usage
11.3.4 Relationships
11.4 Dispensing organization
11.4.1 Identification
11.4.2 Definition
11.4.3 Usage
11.4.4 Relationships
11.5 Prescriber
11.5.1 Identification
11.5.2 Definition
11.5.3 Usage
11.5.4 Relationships
11.6 Prescriber organization
11.6.1 Identification
11.6.2 Definition
11.6.3 Usage
11.6.4 Relationships
11.7 Prescription request identifier
11.7.1 Identification
11.7.2 Definition
11.7.3 Usage
11.7.4 Relationships
11.8 Datetime prescription request written
11.8.1 Identification
11.8.2 Definition
11.8.3 Usage
11.8.4 Relationships
12 Prescriber instruction detail
12.1 Prescriber instruction detail
12.1.1 Identification
12.1.2 Definition
12.1.3 Relationships
12.2 Prescriber instruction recipient
12.2.1 Identification
12.2.2 Definition
12.2.3 Usage
12.2.4 Relationships
12.3 Datetime prescriber instruction received
12.3.1 Identification
12.3.2 Definition
12.3.3 Usage
12.3.4 Relationships
12.4 Prescriber instruction
12.4.1 Identification
12.4.2 Definition
12.4.3 Relationships
12.5 Prescriber instruction source
12.5.1 Identification
12.5.2 Definition
12.5.3 Usage
12.5.4 Relationships
12.6 Prescriber instruction communication medium
12.6.1 Identification
12.6.2 Definition
12.6.3 Value domain
12.6.4 Relationships
12.7 Prescriber instruction communication medium values
12.7.1 Identification
12.7.2 Definition
12.7.3 Value domain
12.7.4 Relationships
13 Prescription request item
13.1 Prescription request item
13.1.1 Identification
13.1.2 Definition
13.1.3 Relationships
13.2 Prescription request item identifier
13.2.1 Identification
13.2.2 Definition
13.2.3 Usage
13.2.4 Relationships
13.3 Dispense item identifier
13.3.1 Identification
13.3.2 Definition
13.3.3 Usage
13.3.4 Relationships
13.4 Therapeutic good identification
13.4.1 Identification
13.4.2 Definition
13.4.3 Usage
13.4.4 Relationships
13.5 Medicines terminology
13.5.1 Identification
13.5.2 Definition
13.5.3 Value domain
13.5.4 Relationships
13.6 Formula
13.6.1 Identification
13.6.2 Definition
13.6.3 Usage
13.6.4 Relationships
13.7 Directions
13.7.1 Identification
13.7.2 Definition
13.7.3 Usage
13.7.4 Relationships
13.8 Structured dose
13.8.1 Identification
13.8.2 Definition
13.8.3 Usage
13.8.4 Relationships
13.9 Quantity
13.9.1 Identification
13.9.2 Definition
13.9.3 Relationships
13.10 Dose unit
13.10.1 Identification
13.10.2 Definition
13.10.3 Usage
13.10.4 Relationships
13.11 Dose unit reference set
13.11.1 Identification
13.11.2 Definition
13.11.3 Value domain
13.11.4 Relationships
13.12 Quantity description
13.12.1 Identification
13.12.2 Definition
13.12.3 Relationships
13.13 Timing
13.13.1 Identification
13.13.2 Definition
13.13.3 Usage
13.13.4 Relationships
13.14 Timing description
13.14.1 Identification
13.14.2 Definition
13.14.3 Usage
13.14.4 Relationships
13.15 Structured timing
13.15.1 Identification
13.15.2 Definition
13.15.3 Relationships
13.16 Intervention frequency range
13.16.1 Identification
13.16.2 Definition
13.16.3 Relationships
13.17 Intervention interval range
13.17.1 Identification
13.17.2 Definition
13.17.3 Relationships
13.18 Intervention time
13.18.1 Identification
13.18.2 Definition
13.18.3 Relationships
13.19 Intervention day of week
13.19.1 Identification
13.19.2 Definition
13.19.3 Usage
13.19.4 Relationships
13.20 Intervention day of week values
13.20.1 Identification
13.20.2 Definition
13.20.3 Value domain
13.20.4 Relationships
13.21 Intervention day of month
13.21.1 Identification
13.21.2 Definition
13.21.3 Relationships
13.22 Intervention date
13.22.1 Identification
13.22.2 Definition
13.22.3 Relationships
13.23 PRN
13.23.1 Identification
13.23.2 Definition
13.23.3 Relationships
13.24 Start criterion
13.24.1 Identification
13.24.2 Definition
13.24.3 Relationships
13.25 Start date
13.25.1 Identification
13.25.2 Definition
13.25.3 Relationships
13.26 Stop criterion
13.26.1 Identification
13.26.2 Definition
13.26.3 Relationships
13.27 Stop date
13.27.1 Identification
13.27.2 Definition
13.27.3 Relationships
13.28 Duration of treatment
13.28.1 Identification
13.28.2 Definition
13.28.3 Relationships
13.29 Number of administrations
13.29.1 Identification
13.29.2 Definition
13.29.3 Relationships
13.30 Long-term
13.30.1 Identification
13.30.2 Definition
13.30.3 Relationships
13.31 Administration details
13.31.1 Identification
13.31.2 Definition
13.31.3 Usage
13.31.4 Relationships
13.32 Route
13.32.1 Identification
13.32.2 Definition
13.32.3 Usage
13.32.4 Relationships
13.33 Route of administration reference set
13.33.1 Identification
13.33.2 Definition
13.33.3 Value domain
13.33.4 Relationships
13.34 Anatomical site
13.34.1 Identification
13.34.2 Definition
13.34.3 Usage
13.34.4 Relationships
13.35 Body structure foundation reference set
13.35.1 Identification
13.35.2 Definition
13.35.3 Value domain
13.35.4 Relationships
13.36 Medication delivery method
13.36.1 Identification
13.36.2 Definition
13.36.3 Usage
13.36.4 Relationships
13.37 Dose duration
13.37.1 Identification
13.37.2 Definition
13.37.3 Usage
13.37.4 Relationships
13.38 Quantity to dispense
13.38.1 Identification
13.38.2 Definition
13.38.3 Relationships
13.39 Quantity
13.39.1 Identification
13.39.2 Definition
13.39.3 Relationships
13.40 Dispensing unit
13.40.1 Identification
13.40.2 Definition
13.40.3 Usage
13.40.4 Relationships
13.41 Dose unit reference set
13.41.1 Identification
13.41.2 Definition
13.41.3 Value domain
13.41.4 Relationships
13.42 Quantity description
13.42.1 Identification
13.42.2 Definition
13.42.3 Relationships
13.43 Brand substitute not allowed
13.43.1 Identification
13.43.2 Definition
13.43.3 Usage
13.43.4 Relationships
13.44 PBS Prescription type
13.44.1 Identification
13.44.2 Definition
13.44.3 Usage
13.44.4 Relationships
13.45 PBS Prescription type values
13.45.1 Identification
13.45.2 Definition
13.45.3 Value domain
13.45.4 Relationships
13.46 Medical benefit category type
13.46.1 Identification
13.46.2 Definition
13.46.3 Relationships
13.47 Medical benefit category type values
13.47.1 Identification
13.47.2 Definition
13.47.3 Value domain
13.47.4 Relationships
13.48 PBS Close the gap benefit
13.48.1 Identification
13.48.2 Definition
13.48.3 Usage
13.48.4 Relationships
13.49 PBS/RPBS Item code
13.49.1 Identification
13.49.2 Definition
13.49.3 Usage
13.49.4 Relationships
13.50 PBS/RPBS Item code values
13.50.1 Identification
13.50.2 Definition
13.50.3 Value domain
13.50.4 Relationships
13.51 PBS/RPBS Manufacturer code
13.51.1 Identification
13.51.2 Definition
13.51.3 Usage
13.51.4 Relationships
13.52 PBS/RPBS Manufacturer Code Values
13.52.1 Identification
13.52.2 Definition
13.52.3 Value domain
13.52.4 Relationships
13.53 PBS Extemporaneous preparation description
13.53.1 Identification
13.53.2 Definition
13.53.3 Usage
13.53.4 Relationships
13.54 PBS Extemporaneous ingredient
13.54.1 Identification
13.54.2 Definition
13.54.3 Usage
13.54.4 Relationships
13.55 PBS Extemporaneous ingredient name
13.55.1 Identification
13.55.2 Definition
13.55.3 Usage
13.55.4 Relationships
13.56 PBS Extemporaneous ingredient quantity
13.56.1 Identification
13.56.2 Definition
13.56.3 Relationships
13.57 PBS/RPBS Authority prescription number
13.57.1 Identification
13.57.2 Definition
13.57.3 Usage
13.57.4 Relationships
13.58 PBS/RPBS Authority approval number
13.58.1 Identification
13.58.2 Definition
13.58.3 Usage
13.58.4 Relationships
13.59 Streamlined authority approval number
13.59.1 Identification
13.59.2 Definition
13.59.3 Usage
13.59.4 Relationships
13.60 State authority number
13.60.1 Identification
13.60.2 Definition
13.60.3 Usage
13.60.4 Relationships
13.61 Additional comments
13.61.1 Identification
13.61.2 Definition
13.61.3 Usage
13.61.4 Relationships
14 Requester note
14.1 Requester note
14.1.1 Identification
14.1.2 Definition
14.1.3 Relationships
14.2 Note
14.2.1 Identification
14.2.2 Definition
14.2.3 Usage
14.2.4 Relationships
Appendix A
A1 General
A2 Subject of care
A2.1 General
A2.2 Data hierarchy
A2.3 Constraints on data values
A3 Prescriber
A3.1 General
A3.2 Data hierarchy
A3.3 Constraints on data values
A4 Prescriber organization
A4.1 General
A4.2 Data hierarchy
A4.3 Constraints on data values
A5 Dispenser
A5.1 General
A5.2 Data hierarchy
A5.3 Constraints on data values
A6 Dispensing organization
A6.1 General
A6.2 Data hierarchy
A6.3 Constraints on data values
Appendix B
B1 Introduction
B2 Mapping from printed to e-prescriptions
Bibliography
Cited references in this standard
[Current]
Electronic transfer of prescriptions, Part 2: Platform independent (logical) services model to support electronic transfer of prescriptions
[Current]
Electronic transfer of prescriptions, Part 6: Platform implementation specific web service
[Current]
Electronic transfer of prescriptions, Part 5: Platform implementation specific prescription request HL7 Clinical Document Architecture implementation guide
[Current]
Electronic transfer of prescriptions, Part 4: Platform implementation specific dispense record HL7 Clinical Document Architecture implementation guide
[Current]
Electronic transfer of prescriptions, Part 3: Platform implementation specific e-prescription HL7 Clinical Document Architecture implementation guide
Content history
One-time Purchase
Access via web browser on any device
One-time purchase
Single publication
Offline access via PDF^
$262.48 AUD
Inclusive of GSTFormat *
Web Reader
Licenses *
1 user
Total$262.48 AUD
IMPORTANT